Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia
Introduction. Atrial fibrillation (AF) is the major cause ofstroke, particularly in older patients over 75 years of age. EuropeanSociety of Cardiology guidelines recommend chronic anticoagulationtherapy in patients with atrial fibrillation ifCHA2DS2-VASc score is ≥ 1 (CHA2DS2-VASc score for estimati...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Military Health Department, Ministry of Defance, Serbia
2017-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600202N.pdf |
| _version_ | 1818146164116029440 |
|---|---|
| author | Nedeljković Milan A. Beleslin Branko Tešić Milorad Vujisić-Tešić Bosiljka Vukčević Vladan Stanković Goran Stojković Siniša Orlić Dejan Potpara Tatjana Mujović Nebojša Marinković Milan Petrović Olga Grygier Marek Protopopov Alexey V. Kanjuh Vladimir Ašanin Milika |
| author_facet | Nedeljković Milan A. Beleslin Branko Tešić Milorad Vujisić-Tešić Bosiljka Vukčević Vladan Stanković Goran Stojković Siniša Orlić Dejan Potpara Tatjana Mujović Nebojša Marinković Milan Petrović Olga Grygier Marek Protopopov Alexey V. Kanjuh Vladimir Ašanin Milika |
| author_sort | Nedeljković Milan A. |
| collection | DOAJ |
| description | Introduction. Atrial fibrillation (AF) is the major cause ofstroke, particularly in older patients over 75 years of age. EuropeanSociety of Cardiology guidelines recommend chronic anticoagulationtherapy in patients with atrial fibrillation ifCHA2DS2-VASc score is ≥ 1 (CHA2DS2-VASc score for estimatingthe risk of stroke in patients with non-rheumatic AFconsisting of the first letters of patients condition: C – congestiveheart failure; H – hypertension; A2 – age ≥ 75 years; D –diabetes mellitus; S2 – prior stroke, transitory ischaemic attack(TIA) or thrombolism; V – vascular disease; A – age 65–74years; Sc – sex category). However, a significant number of patientshave a high bleeding risk, or are contraindicated forchronic oral anticoagulation, and present a group of patients inwhom alternative treatment options for thromboembolic preventionare required. Transcatheter percutaneous left atrial appendageclosure (LAAC) devices have been recommended inpatients with contraindications for chronic anticoagulanttherapy. Case report. We present our first three patients withnonvalvular AF and contraindications for chronic anticoagulanttherapy who were successfully treated with implantation ofLAAC Watchman device in Catheterization Laboratory of theClinic for Cardiology, Clinical Center of Serbia in BelgradeConclusion. Our initial results with Watchman LAAC deviceare promising and encouraging, providing real alternative in patientswith non-valvular AF and contraindication for chronicanticoagulant therapy and high bleeding risk. |
| first_indexed | 2024-12-11T12:15:00Z |
| format | Article |
| id | doaj.art-77cfe73cf85d43ab9f6991cd4a397d3c |
| institution | Directory Open Access Journal |
| issn | 0042-8450 2406-0720 |
| language | English |
| last_indexed | 2024-12-11T12:15:00Z |
| publishDate | 2017-01-01 |
| publisher | Military Health Department, Ministry of Defance, Serbia |
| record_format | Article |
| series | Vojnosanitetski Pregled |
| spelling | doaj.art-77cfe73cf85d43ab9f6991cd4a397d3c2022-12-22T01:07:40ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502406-07202017-01-0174437838510.2298/VSP160205202N0042-84501600202NLeft atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in SerbiaNedeljković Milan A.0Beleslin Branko1Tešić Milorad2Vujisić-Tešić Bosiljka3Vukčević Vladan4Stanković Goran5Stojković Siniša6Orlić Dejan7Potpara Tatjana8Mujović Nebojša9Marinković Milan10Petrović Olga11Grygier Marek12Protopopov Alexey V.13Kanjuh Vladimir14Ašanin Milika15Clinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeClinical center of Serbia, Clinic for cardiology, BelgradeClinical center of Serbia, Clinic for cardiology, BelgradePoznan University of Medical Sciences, Department of Cardiology, Poznan, PolandState Clinical Hospital, Krasnoyarsk Medical University by the name of prof. V.F. Voino-Yasenetck, Invasive Cardiology Department, Krasnoyarsk, RussiaSerbian Academy of Sciences and Arts, BelgradeClinical center of Serbia, Clinic for cardiology, Belgrade + Medical school, BelgradeIntroduction. Atrial fibrillation (AF) is the major cause ofstroke, particularly in older patients over 75 years of age. EuropeanSociety of Cardiology guidelines recommend chronic anticoagulationtherapy in patients with atrial fibrillation ifCHA2DS2-VASc score is ≥ 1 (CHA2DS2-VASc score for estimatingthe risk of stroke in patients with non-rheumatic AFconsisting of the first letters of patients condition: C – congestiveheart failure; H – hypertension; A2 – age ≥ 75 years; D –diabetes mellitus; S2 – prior stroke, transitory ischaemic attack(TIA) or thrombolism; V – vascular disease; A – age 65–74years; Sc – sex category). However, a significant number of patientshave a high bleeding risk, or are contraindicated forchronic oral anticoagulation, and present a group of patients inwhom alternative treatment options for thromboembolic preventionare required. Transcatheter percutaneous left atrial appendageclosure (LAAC) devices have been recommended inpatients with contraindications for chronic anticoagulanttherapy. Case report. We present our first three patients withnonvalvular AF and contraindications for chronic anticoagulanttherapy who were successfully treated with implantation ofLAAC Watchman device in Catheterization Laboratory of theClinic for Cardiology, Clinical Center of Serbia in BelgradeConclusion. Our initial results with Watchman LAAC deviceare promising and encouraging, providing real alternative in patientswith non-valvular AF and contraindication for chronicanticoagulant therapy and high bleeding risk.http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600202N.pdfatrial fibrillationcerebrovascular disordersrisk assessmenttherapeutic occlusionheart atria |
| spellingShingle | Nedeljković Milan A. Beleslin Branko Tešić Milorad Vujisić-Tešić Bosiljka Vukčević Vladan Stanković Goran Stojković Siniša Orlić Dejan Potpara Tatjana Mujović Nebojša Marinković Milan Petrović Olga Grygier Marek Protopopov Alexey V. Kanjuh Vladimir Ašanin Milika Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia Vojnosanitetski Pregled atrial fibrillation cerebrovascular disorders risk assessment therapeutic occlusion heart atria |
| title | Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia |
| title_full | Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia |
| title_fullStr | Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia |
| title_full_unstemmed | Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia |
| title_short | Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia |
| title_sort | left atrial appendage closure with watchman device in prevention of thromboembolic complications in patients with atrial fibrillation first experience in serbia |
| topic | atrial fibrillation cerebrovascular disorders risk assessment therapeutic occlusion heart atria |
| url | http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600202N.pdf |
| work_keys_str_mv | AT nedeljkovicmilana leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT beleslinbranko leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT tesicmilorad leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT vujisictesicbosiljka leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT vukcevicvladan leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT stankovicgoran leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT stojkovicsinisa leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT orlicdejan leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT potparatatjana leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT mujovicnebojsa leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT marinkovicmilan leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT petrovicolga leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT grygiermarek leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT protopopovalexeyv leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT kanjuhvladimir leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia AT asaninmilika leftatrialappendageclosurewithwatchmandeviceinpreventionofthromboemboliccomplicationsinpatientswithatrialfibrillationfirstexperienceinserbia |